At a glance
ClinicalIndex Comparison RecordN/ACompleted· 59 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feraccru® Real World Effectiveness Study in Hospital Practice (FRESH): A Real World Study to Describe the Outcomes Associated With the Use of Ferric Maltol (Feraccru) for the Management of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease in the UK.
In Brief
An observational study for Anemia, Iron Deficiency and Inflammatory Bowel Diseases. Completed, enrolled 59 participants across 1 site.
Detailed Summary
The aim of the study is to understand the early experiences of Feraccru® in patients with inflammatory bowel disease (IBD) and iron deficiency anaemia (IDA) in the UK, including treatment effectiveness, patterns of use and tolerability.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 2017
Enrollment StartAug 2017
Primary CompletionMar 2018
Study CompletionOct 2018
TodayJul 2026
First PostedAug 14, 2017
Enrollment StartAug 14, 2017
Primary CompletionMar 1, 2018
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.9 years ago